On March 10, 2017, Inocucor Technologies Inc. secured $38.8 million in the first tranche closing of a Series B financing. The round was led by TPG Alternative and Renewable Technologies (“TPG ART”).
Inocucor Technologies is leading innovator and producer of sustainable biological crop inputs. Their patented fermentation process aims to naturally improve crop yields, shorten growing periods, and strengthen the health and resilience of soils for farmers and greenhouse growers.
TPG ART is a growth-equity and late-stage venture capital vehicle of global alternative asset firm TPG. The fund seeks to invest in technologies to reduce environmental impact and promote resource efficiency.
Osler, Hoskin & Harcourt LLP represented Inocucor Corporation and Inocucor Technologies Inc. with a team consisting of Nathalie Beauregard (Corporate), Mark Brender, Alain Fournier, Paul Seraganian, Jennifer Lee, David Wilson (Tax), and Ziyi Shi and Guillaume Falardeau (Corporate).
Key Contact
Partner, Emerging and High Growth Companies, Montréal
Team
Partner, Tax, Montréal
Partner, Tax, Montréal
Partner, Tax, Montréal
